|
Quotes & Info
|
| IDXX > SEC Filings for IDXX > Form 8-K on 21-Jul-2009 | All Recent SEC Filings |
21-Jul-2009
Change in Directors or Principal Officers
Effective July 15, 2009, Dr. Errol B. De Souza retired as a member of the Board
of Directors (the "Board") of IDEXX Laboratories, Inc. (the "Company"). His
decision to retire was not as a result of any disagreement with the Company or
its management.
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal
Year.
On July 15, 2009, the Board adopted and approved amendments (the "Amendments")
to the Company's Amended and Restated By-Laws (the "By-Laws") to (i) revise and
expand the advance notice requirements for stockholder proposals at annual
meetings and nominations of directors and (ii) modify the provisions relating to
share certificates, uncertificated shares and transfers of shares. The
Amendments took effect on July 15, 2009, in accordance with the resolutions
adopted by the Board.
Pursuant to the amended advance notice requirements, for stockholder proposals
and nominations of directors in connection with our 2010 annual meeting, the
Company must receive notice of any nomination of directors or proposed item of
business, and all required supporting information, no earlier than January 6,
2010 and no later than February 5, 2010, assuming the meeting is held between
April 16, 2010 and July 5, 2010 as is currently expected. The deadline for
stockholder proposals submitted pursuant to Rule 14a-8 under the SEC rules for
inclusion in our proxy materials for our 2010 annual meeting of stockholders
continues to be November 26, 2009.
The description above regarding the Amendments to the Company's By-Laws is
qualified in its entirety by reference to the full text of such amended By-Laws,
a copy of which is filed as Exhibit 3.1 to this Current Report on Form 8-K, and
incorporated herein by reference. The copy is marked to show changes from the
prior By-Laws.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
3.1 Amended and Restated By-Laws of IDEXX Laboratories, Inc., effective as of July 15, 2009.
|
|